枸橼酸氯米芬治疗不孕症与死产或新生儿死亡风险:一项基于人群的队列研究
该研究基于南澳大利亚2003年7月至2015年12月全部242,077例分娩数据,将政府发药记录与出生记录链接,评估枸橼酸氯米芬(CC)暴露与围产期死亡的关系。单胎中,CC暴露者死产和新生儿死亡合计的比值比为1.54(95%CI 1.15, 2.07),校正生物学和社会风险因素后稳定。结论认为使用CC后妊娠的围产期死亡风险可能增加,但可能存在潜在不孕症的残余贡献。
要点
- 单胎中死产率为6.6/1000例分娩,新生儿死亡率为2.1/1000例活产。
- 单胎中CC暴露者死产率为10.2/1000,新生儿死亡率为3.1/1000。
- CC暴露与围产期死亡合计的OR为1.54(95%CI 1.15, 2.07),校正后稳定。
核心结论
- 使用CC后妊娠的围产期死亡风险可能增加,但可能存在潜在不孕症的残余贡献。
研究设计与样本
- 全人群数据链接队列研究,纳入2003年7月至2015年12月南澳大利亚所有分娩女性(n=242,077)。
- 所有至少20周的分娩与政府发药记录链接,从受孕窗口前90天至窗口结束期间发放CC处方定义为暴露。
- 单胎采用多变量logistic回归模型分析CC暴露与围产期死亡合计结局的关联。
主要发现
- 单胎中死产率为6.6/1000例分娩,新生儿死亡率为2.1/1000例活产。
- 单胎中CC暴露者死产率为10.2/1000,新生儿死亡率为3.1/1000。
- 单胎中CC暴露与围产期死亡合计的OR为1.54(95%CI 1.15, 2.07),校正生物学和社会风险因素后稳定。
局限性
- 原文指出尽管已考虑与不孕症相关的既定混杂因素,但仍可能存在潜在不孕症的残余贡献。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess associations between clomiphene citrate (CC) use and perinatal death. DESIGN: Whole of population data linkage cohort. SETTING: South Australia. PARTICIPANTS: All women giving birth between July 2003 and December 2015 (n = 242,077). METHODS: All births of at least 20 weeks were linked to government records of dispensed medications. A pregnancy was considered exposed to CC if a prescription was dispensed from 90 days before through to the end of a conception window. Descriptive statistics for stillbirths and neonatal deaths were stratified by multiplicity. For singletons, multivariable logistic regression models were used to examine the association of CC exposure with the combined outcome of perinatal death. MAIN OUTCOME MEASURES: Stillbirths and neonatal deaths (with 28 days of birth) combined as perinatal deaths. RESULTS: Among singletons, the prevalence of stillbirth was 6.6 per 1000 births, with neonatal deaths of 2.1 per 1000 live births. Among singletons conceived with CC, stillbirth and neonatal death had a prevalence of 10.2 and 3.1 per 1000, respectively. For the combined outcome of perinatal death, the odds ratio was 1.54 (95% confidence interval 1.15, 2.07), stable upon adjustment for factors conveying biological (eg, obesity, pregestational diabetes) and social (eg, disadvantage) risks for perinatal death. CONCLUSION: Risk of perinatal death may be increased in pregnancies that follow use of CC. While established confounding factors related to infertility were taken into account, there may be some residual contribution of underlying infertility.
引用
- Moore V, Rumbold A, Fernandez R, et al. Clomiphene Citrate Medication for Infertility and Risk of Stillbirth or Neonatal Death: A Population-based Cohort Study. J Clin Endocrinol Metab. 2025. PMID: 39437266. doi:10.1210/clinem/dgae741
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。